RobertSuddathMD

PubMed

• Social impairment in relation to clinical symptoms in youth at high risk for bipolar disorder.
  Marc J. Weintraub, Danielle Keenan-Miller, Christopher D. Schneck, Marcy Forgey Borlik, Robert L Suddath, Sarah E Marvin, Manpreet K. Singh, Kiki D. Chang, David J. Mi...> ;Early Intervention in Psychiatry. 2021 Feb 8
• 37 citations
  Effects of Family-Focused Therapy vs Enhanced Usual Care for Symptomatic Youths at High Risk for Bipolar Disorder: A Randomized Clinical Trial.
  David J. Miklowitz, Christopher D. Schneck, Patricia D. Walshaw, Manpreet K. Singh, Aimee E. Sullivan, Robert Suddath, Marcy Forgey Borlik, Catherine A. Sugar, Kiki D....> ;JAMA Psychiatry. 2020 May 1
• 14 citations
  Is it time to retire fragile X testing as a first-tier test for developmental delay, intellectual disability, and autism spectrum disorder?
  Sureni V. Mullegama, Steven D Klein, Dzung C Nguyen, Arang Kim, Rebecca Signer, Michelle Fox, Naghmeh Dorrani, Andrea Hendershot, Rebecca Mardach, Robert Suddath, Katr...> ;Genetics in Medicine. 2017 Sep 21
• 4 citations
  Diagnostic profiles and clinical characteristics of youth referred to a pediatric mood disorders clinic.
  Marc J. Weintraub, Eric A. Youngstrom, Sarah E Marvin, Jennifer L. Podell, Patricia D. Walshaw, Eunice Y. Kim, Robert Suddath, Marcy J Forgey-Borlick, Brittany N Matke...> ;Journal of Psychiatric Practice. 2014 Mar 1
• 133 citations
  An emergency department intervention for linking pediatric suicidal patients to follow-up mental health treatment.
  Joan Rosenbaum Asarnow, Larry J. Baraff, Michele S. Berk, Charles S. Grob, Mona Devich-Navarro, Robert Suddath, John Piacentini, Mary Jane Rotheram-Borus, Daniel Cohen...> ;Psychiatric Services. 2011 Nov 1
• 32 citations
  Incremental Cost-effectiveness of Combined Therapy vs Medication Only for Youth With Selective Serotonin Reuptake Inhibitor-Resistant Depression Treatment of SSRI-Resi...
  Frances L. Lynch, John F. Dickerson, Greg Clarke, Benedetto Vitiello, Giovanna Porta, Karen Dineen Wagner, Graham J. Emslie, Joan Rosenbaum Asarnow, Martin B. Keller, ...> ;Archives of General Psychiatry. 2011 Mar 7
• Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.
  Vitiello, B., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Keller, M. B., Birmaher, B., Ryan, N. D., Kennard, B., Mayes, T. L., DeBar, L., Lynch, F., Dickers...> ;J Clin Psychiatry. 2011 Mar
• 59 citations
  A Candidate Gene Analysis of Methylphenidate Response in Attention-Deficit/Hyperactivity Disorder
  James J. McGough, James T. McCracken, Sandra K. Loo, Marc Manganiello, Michael C. Leung, Jeremy R. Tietjens, Thao Trinh, Shilpa Baweja, Robert Suddath, Susan L. Smalle...> ;Journal of the American Academy of Child and Adolescent Psychiatry. 2009 Dec 1
• 139 citations
  Predictors of Spontaneous and Systematically Assessed Suicidal Adverse Events in the Treatment of SSRI- Resistant Depression in Adolescents (TORDIA) Study
  David A. Brent, Graham J. Emslie, Greg N. Clarke, Joan Rosenbaum Asarnow, Anthony Spirito, Louise Ritz, Benedetto Vitiello, Satish Iyengar, Boris Birmaher, Neal D. Rya...> ;The American Journal of Psychiatry. 2009 Apr 1
• 150 citations
  Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: Predictors and moderators of treatment response
  Joan Rosenbaum Asarnow, Graham J. Emslie, Greg N. Clarke, Karen Dineen Wagner, Anthony Spirito, Benedetto Vitiello, Satish Iyengar, Wael Shamseddeen, Louise Ritz, Bori...> ;Journal of the American Academy of Child and Adolescent Psychiatry. 2009 Mar 1
• 42 citations
  Effectiveness and Tolerability of Open Label Olanzapine in Children and Adolescents with Tourette Syndrome
  James T. McCracken, Robert Suddath, Susanna Chang, Sarika Thakur, John Piacentini> ;Journal of Child and Adolescent Psychopharmacology. 2008 Oct 19
• 53 citations
  Pediatric Emergency Department Suicidal Patients: Two-Site Evaluation of Suicide Ideators, Single Attempters, and Repeat Attempters
  Joan Rosenbaum Asarnow, Larry J. Baraff, Michele S. Berk, Charles S. Grob, Mona Devich-Navarro, Robert Suddath, John Piacentini, Lingqi Tang> ;Journal of the American Academy of Child and Adolescent Psychiatry. 2008 Aug 1
• 391 citations
  Switching to Another SSRI or to Venlafaxine With or Without Cognitive Behavioral Therapy for Adolescents With SSRI-Resistant Depression: The TORDIA Randomized Controll...
  David A. Brent, Graham J. Emslie, Greg Clarke, Karen Dineen Wagner, Joan Rosenbaum Asarnow, M. Keller, Benedetto Vitiello, Louise Ritz, Satish Iyengar, Kaleab Z. Abebe...> ;JAMA. 2008 Feb 27
• 9 citations
  Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorder.
  James J. McGough, Caroly Pataki, Robert Suddath> ;Expert Review of Neurotherapeutics. 2005 Jul 1
• 14 citations
  Violent fantasy, dangerousness, and the duty to warn and protect
  Robert Suddath, David M. Gellerman> ;The Journal of the American Academy of Psychiatry and the Law. 2005 Jan 1
• 36 citations
  Emergency department management of suicidal adolescents.
  Sarah P. Kennedy, Larry J. Baraff, Robert Suddath, Joan Rosenbaum Asarnow> ;Annals of Emergency Medicine. 2004 Apr 1
• Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy.
  Miklowitz, D. J., Simoneau, T. L., George, E. L., Richards, J. A., Kalbag, A., Sachs-Ericsson, N., Suddath, R.> ;Biol Psychiatry. 2000 Sep 15
• Preliminary evidence of the reliability and validity of the prospective life-chart methodology (LCM-p).
  Denicoff, K. D., Smith-Jackson, E. E., Disney, E. R., Suddath, R. L., Leverich, G. S., Post, R. M.> ;J Psychiatr Res. 1997 Nov 22
• Event-related potential abnormalities correlate with structural brain alterations and clinical features in patients with chronic schizophrenia.
  Egan, M. F., Duncan, C. C., Suddath, R. L., Kirch, D. G., Mirsky, A. F., Wyatt, R. J.> ;Schizophr Res. 1994 Feb
• Interleukin-1 alpha and interleukin-2 in cerebrospinal fluid of schizophrenic subjects.
  el-Mallakh, R. S., Suddath, R. L., Wyatt, R. J.> ;Prog Neuropsychopharmacol Biol Psychiatry. 1993 May
• 6-[18F]fluoro-L-dopa and cerebral blood flow in unilaterally MPTP-treated monkeys.
  Doudet DJ, Wyatt RJ, Cannon-Spoor E, Suddath R, McLellan CA, Cohen RM> ;J Neural Transplant Plast. 1993-01-01
• Cerebrospinal fluid and serum levels of neuron-specific enolase in patients with schizophrenia.
  Egan, M. F., el-Mallakh, R. S., Suddath, R. L., Lohr, J. B., Bracha, H. S., Wyatt, R. J.> ;Psychiatry Res. 1992 Aug
• Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic ...
  Weinberger, D. R., Berman, K. F., Suddath, R., Torrey, E. F.> ;Am J Psychiatry. 1992 Jul
• Blood-CSF barrier permeability and central nervous system immunoglobulin G in schizophrenia.
  Kirch, D. G., Alexander, R. C., Suddath, R. L., Papadopoulos, N. M., Kaufmann, C. A., Daniel, D. G., Wyatt, R. J.> ;J Neural Transm Gen Sect. 1992
• A clinical trial of nifedipine in schizophrenia and tardive dyskinesia.
  Suddath, R. L., Straw, G. M., Freed, W. J., Bigelow, L. B., Kirch, D. G., Wyatt, R. J.> ;Pharmacol Biochem Behav. 1991 Jul
• Join now to see all